Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

18.63
-0.0100-0.05%
Volume:1.04M
Turnover:19.28M
Market Cap:3.62B
PE:-37.20
High:18.80
Open:18.80
Low:18.22
Close:18.64
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:0.83
T/O Rate:1.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:2.95
PE(LYR):-11.50

Loading ...

Genscript flags Legend Biotech Q1 results and cautions investors on risk

TIPRANKS
·
May 12

Legend Biotech Q1 2026 Results Show CARVYKTI-Fueled Revenue Surge and Narrowing Losses

TIPRANKS
·
May 12

Legend Biotech Q1 revenue slightly misses estimates

Reuters
·
May 12

Legend Biotech Q1 FY26 net loss narrows 46.24% to $54.3 million; revenue rises to $305.1 million

Reuters
·
May 12

Legend Biotech Q1 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $305.100M Miss $307.035M Estimate

Benzinga Earnings
·
May 12

Legend Biotech Corp - Reports Cash and Cash Equivalents, Time Deposits of $834.6 Mln as of March 31, 2026

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Pretax Profit USD -53.1 Million

THOMSON REUTERS
·
May 12

Legend Biotech Corporation Q1 Adjusted EPS USD -0.03 VS. Ibes Estimate USD -0.02

THOMSON REUTERS
·
May 12

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights

GlobeNewswire
·
May 12

Legend Biotech's Q1 2026 Earnings Preview: CARVYKTI Sales Projected at Approximately $597 Million

Deep News
·
May 11

Earning Preview: Legend Biotech Q1 revenue is expected to increase by 58.58%, and institutional views are bullish

Earnings Agent
·
May 05

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth

GlobeNewswire
·
May 04

Is Growing Focus On CAR-T Data And CARVYKTI Orders Reframing Legend Biotech’s (LEGN) Investment Story?

Simply Wall St.
·
May 02

Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results

GlobeNewswire
·
Apr 28

Legend Biotech Soars Over 40% in 5 Days: Is Lilly's $7B Bet Revealing a Deeply Undervalued Gem?

Stock News
·
Apr 22

Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 21

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

Legend Biotech Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 15

BUZZ-Genscript Biotech climbs as cancer drug CARVYKTI generated $597 mln sales

Reuters
·
Apr 15

Legend Biotech Reports Preliminary Q1 2026 CARVYKTI Sales of About $597 Million

TIPRANKS
·
Apr 14